Gilles de Preux, CEO, SSE Holding, Valsynthese

MAGAZINE 2022 | March / April 2022

Global campaigns towards local manufacture of anti-HIV/AIDS drugs in c...

by F. M. Akwi, P. Watts • April 12, 2022

MAGAZINE 2022 | March / April 2022

Around the Block(chain) – applications in pharma

by R. Sharif • April 12, 2022

MAGAZINE 2022 | March / April 2022

Safety at the base of the choice of SIT (specific immunotherapy)

by F. Frati, F. Silvestri, A. Pisani, E. Compalati • April 12, 2022

MAGAZINE 2022 | March / April 2022

EFPIA and Vaccines Europe position on the European Health Emergency pr...

April 12, 2022

MAGAZINE 2022 | March / April 2022

Pharma 4.0 manufacturing optimization using eData

by S. M. Wing • April 12, 2022

MAGAZINE 2022 | March / April 2022

The future of remote pharma GMP auditing

by A. Leckie • April 12, 2022

MAGAZINE 2022 | March / April 2022

POST-SHOW – DCAT Week 2022: Welcome back to NYC!

April 12, 2022

MAGAZINE 2022 | March / April 2022

Panel discussion on OLIGONUCLEOTIDES

by K. L. Ackley • April 12, 2022

MAGAZINE 2022 | March / April 2022

Extractable and Leachables in drug products – The toxicological...

by A. Conto • April 12, 2022